Original Packaging Format – Pre May 2020
BÜHLMANN presented an Educational Workshop at EuroMedLab 2019 about optimising the
As you may have seen from the NEQAS reports, the BÜHLMANN
The following video demonstrates faecal sample extraction using the BÜHLMANN CALEX®
Faecal Calprotectin is a new biomarker which is helping to save money for the NHS by preventing unnecessary procedures on patients by screening out patients with IBS who do not require endoscopies.
The symptoms of functional disorders such as Irritable Bowel Syndrome (IBS) and organic inflammatory intestinal disease (IBD) can be very similar in presentation but are two very different medical conditions.
Calprotectin is Now Part of the New ECCO & ESGAR Guidelines August 8, 2019
The New Faecal Calprotectin Care Pathway | NICE February 1, 2019
Big Changes Coming Soon to a Clinic Near You March 9, 2018